Clinical Trial Update: Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial [Phase 3]

View source ↗

Summary

Phase 3 VWD-WOMAN trial evaluating prevention of postpartum hemorrhage in women with von Willebrand disease has completed and posted results as of 2025-10-31.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Von Willebrand Disease

Snippet

Sponsor: Nicoletta C Machin | Conditions: Von Willebrand Diseases, Postpartum Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2025-10-31